Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 30:9:978346.
doi: 10.3389/fmed.2022.978346. eCollection 2022.

Postoperative complications of combined phacoemulsification and pars plana vitrectomy in diabetic retinopathy patients

Affiliations

Postoperative complications of combined phacoemulsification and pars plana vitrectomy in diabetic retinopathy patients

Assaf Gershoni et al. Front Med (Lausanne). .

Abstract

Purpose: To compare intra- and postoperative complications in combined phacoemulsification and pars plana vitrectomy surgeries performed in patients with non-proliferative diabetic retinopathy (NPDR) vs. proliferative diabetic retinopathy (PDR).

Methods: Retrospective, case series of patients with diabetic retinopathy who underwent combined phacovitrectomy surgery between 2008 and 2017. We compared intraoperative complications including posterior capsular rupture and retinal tear, and postoperative complications including corneal edema, macular edema (ME), epiretinal membrane (ERM), neovascular glaucoma and persistent inflammation.

Results: A total of 104 eyes of 104 patients were included in this study. Twenty-four eyes (23.1%) were categorized as NPDR and 80 eyes (76.9%) as PDR. The most common indications for surgery in the NPDR group were ERM (67%) and rhegmatogenous retinal detachment (12.5%), while in the PDR group, indications were vitreous hemorrhage (56%) and tractional retinal detachment (19%). The most common intraoperative complication was retinal tear (8% in NPDR and 19% in PDR, p = 0.195) and postoperative complication was ME (29% in NPDR and 26% in PDR, p = 0.778). There were no statistically significant differences in intra- and postoperative complication rates between the NPDR and PDR groups, even after adjusting for confounders; patient age at surgery and indication for surgery.

Conclusion: After combined phacovitrectomy in NPDR and PDR patients, new-onset ME was found in about a quarter of eyes in both groups. Intraoperative anti-VEGF or steroid administration, and intense postoperative anti-inflammatory medication and follow-up should be regarded after phacovitrectomy regardless of the DR level.

Keywords: cystoid macular edema (CME); non-proliferative diabetic retinopathy (NPDR); phacoemulsification (phaco); proliferative diabetic retinopathy (PDR); vitrectomy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. . Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. (2012) 35:556–64. 10.2337/dc11-1909 - DOI - PMC - PubMed
    1. Hamill EB, Ali SF, Weng CY. An update in the management of proliferative diabetic retinopathy. Int Ophthalmol Clin. (2016) 56:209–25. 10.1097/IIO.0000000000000136 - DOI - PubMed
    1. ETDRS Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. (1985) 103:1796–806. 10.1001/archopht.1985.01050120030015 - DOI - PubMed
    1. Helbig H. Surgery for diabetic retinopathy. Ophthalmologica. (2007) 221:103–11. 10.1159/000098255 - DOI - PubMed
    1. Klein BEK, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin epidemiologic study of diabetic retinopathy. Am J Ophthalmol. (1995) 119:295–300. 10.1016/S0002-9394(14)71170-5 - DOI - PubMed